Freeman. In a research update to clients January 7, the analyst upgraded Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP) from “Outpeform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback